MAPT and Alzheimer disease: While very little is known about this particular mutation and its underlying pathology, which precludes further conclusions, this result does offer potential for more investigations in familial AD, particularly future longitudinal assessments in patients in the presymptomatic stages; this would certainly allow the collection of valuable information on the role of tau in the disease course at the earliest stages.